CIA, a Novel Estrogen Receptor Coactivator with a Bifunctional Nuclear Receptor Interacting Determinant

REFERENCES

• Altschul, S. F., T. L. Madden, A. A. Schaffer, J. Zhang, Z. Zhang, W. Miller, and D. J. Lipman. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:3389–3402.
   PubMed Web of Science ®Google Scholar
• Anzick, S. L., J. Kononen, R. L. Walker, D. O. Azorsa, M. M. Tanner, X.-Y. Guan, G. Sauter, O.-P. Kallioniemi, J. M. Trent, and P. S. Meltzer. 1997. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277:965–968.
   PubMed Web of Science ®Google Scholar
• Bartel, P., C. T. Chien, R. Sternglanz, and S. Fields. 1993. Elimination of false positives that arise in using the two-hybrid system. BioTechniques 14:920–924.
   PubMed Web of Science ®Google Scholar
• Bautista, S., H. Valles, R. L. Walker, S. Anzick, R. Zeillinger, P. Meltzer, and C. Theillet. 1998. In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity. Clin. Cancer Res. 4:2925–2929.
   PubMedGoogle Scholar
• Berry, M., D. Metzger, and P. Chambon. 1990. Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J. 9:2811–2818.
   PubMed Web of Science ®Google Scholar
• Berry, M., A.-M. Nunez, and P. Chambon. 1989. Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence. Proc. Natl. Acad. Sci. USA 86:1218–1222.
   PubMed Web of Science ®Google Scholar
• Brzozowski, A. M., A. C. W. Pike, Z. Dauter, R. E. Hubbard, T. Bonn, L. Engström, G. L. Greene, J.-Å. Gustafsson, and M. Carlquist. 1997. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389:753–758.
   PubMed Web of Science ®Google Scholar
• Burris, T. P., Z. Nawaz, M. J. Tsai, and B. W. O'Malley. 1995. A nuclear hormone receptor-associated protein that inhibits transactivation by the thyroid hormone and retinoic acid receptors. Proc. Natl. Acad. Sci. USA 92:9525–9529.
   PubMedGoogle Scholar
• Chang, C.-Y., J. D. Norris, H. Grøn, L. A. Paige, P. T. Hamilton, D. J. Kenan, D. Fowlkes, and D. P. McDonnell. 1999. Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: discovery of peptide antagonists of estrogen receptors α and β. Mol. Cell. Biol. 19:8226–8239.
   PubMed Web of Science ®Google Scholar
• Chen, J. D., and R. M. Evans. 1995. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454–457.
   PubMed Web of Science ®Google Scholar
• Chien, C. T., P. L. Bartel, R. Sternglanz, and S. Fields. 1991. The two-hybrid system: a method to identify and clone genes for proteins that interact with a protein of interest. Proc. Natl. Acad. Sci. USA 88:9578–9582.
   PubMed Web of Science ®Google Scholar
• Collingwood, T. N., O. Rajanayagam, M. Adams, R. Wagner, V. Cavailles, E. Kalkhoven, C. Matthews, E. Nystrom, K. Stenlof, G. Lindstedt, L. Tisell, R. J. Fletterick, M. G. Parker, and V. K. Chatterjee. 1997. A natural transactivation mutation in the thyroid hormone β receptor: impaired interaction with putative transcriptional mediators. Proc. Natl. Acad. Sci. USA 94:248–253.
   PubMedGoogle Scholar
• Couse, J. F., and K. S. Korach. 1999. Estrogen receptor null mice: what have we learned and where will they lead us?. Endocr. Rev. 20:358–417.
   PubMed Web of Science ®Google Scholar
• Darimont, B. D., R. L. Wagner, J. W. Apriletti, M. R. Stallcup, P. J. Kushner, J. D. Baxter, R. J. Fletterick, and K. R. Yamamoto. 1998. Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev. 12:3343–3356.
   PubMed Web of Science ®Google Scholar
• Davidson, N. E., and M. E. Lippman. 1989. The role of estrogens in growth regulation of breast cancer. Crit. Rev. Oncol. 1:89–111.
   Google Scholar
• Ding, X. F., C. M. Anderson, H. Ma, H. Hong, R. M. Uht, P. J. Kushner, and M. R. Stallcup. 1998. Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities. Mol. Endocrinol. 12:302–313.
   PubMedGoogle Scholar
• Durfee, T., K. Becherer, P. L. Chen, S. H. Yeh, Y. Yang, A. E. Kilburn, W. H. Lee, and S. J. Elledge. 1993. The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit. Genes Dev. 7:555–569.
   PubMed Web of Science ®Google Scholar
• Feng, W., R. C. J. Ribeiro, R. L. Wagner, H. Nguyen, J. W. Apriletti, R. J. Fletterick, J. D. Baxter, P. J. Kushner, and B. L. West. 1998. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science 280:1747–1749.
   PubMed Web of Science ®Google Scholar
• Giguère, V.. 1999. Orphan nuclear receptors: from gene to function. Endocr. Rev. 20:689–725.
   PubMed Web of Science ®Google Scholar
• Giguère, V., M. Shago, R. Zirngibl, P. Tate, J. Rossant, and S. Varmuza. 1990. Identification of a novel isoform of the retinoic acid receptor γ expressed in the mouse embryo. Mol. Cell. Biol. 10:2335–2340.
   PubMed Web of Science ®Google Scholar
• Glass, C. K., and M. G. Rosenfeld. 2000. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14:121–141.
   PubMed Web of Science ®Google Scholar
• Guan, X. Y., J. Xu, S. L. Anzick, H. Zhang, J. M. Trent, and P. S. Meltzer. 1996. Hybrid selection of transcribed sequences from microdissected DNA: isolation of genes within amplified region at 20q11–13.2 in breast cancer. Cancer Res. 56:3446–3450.
   PubMedGoogle Scholar
• Heery, D. M., E. Kalkhoven, S. Hoare, and M. G. Parker. 1997. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387:733–736.
   PubMed Web of Science ®Google Scholar
• Heinzel, T., R. M. Lavinsky, T. M. Mullen, M. Soderstrom, C. D. Laherty, J. Torchia, W. M. Yang, G. Brard, S. D. Ngo, J. R. Davie, E. Seto, R. N. Eisenman, D. W. Rose, C. K. Glass, and M. G. Rosenfeld. 1997. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387:43–48.
   PubMed Web of Science ®Google Scholar
• Hollenberg, S. M., and R. M. Evans. 1988. Multiple and cooperative trans-activation domains of the human glucocorticoid receptor. Cell 55:899–906.
   PubMed Web of Science ®Google Scholar
• Horlein, A. J., A. M. Naar, T. Heinzel, J. Torchia, B. Glass, R. Kurokawa, A. Ryan, Y. Kamel, M. Soderstrom, C. K. Glass, and M. G. Rosenfeld. 1995. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397–404.
   PubMed Web of Science ®Google Scholar
• Hu, X., and M. A. Lazar. 1999. The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature 402:93–96.
   PubMed Web of Science ®Google Scholar
• Huang, E. Y., J. Zhang, E. A. Miska, M. G. Guenther, T. Kouzarides, and M. A. Lazar. 2000. Nuclear receptor corepressors partner with class II histone deacetylases in a Sin3-independent repression pathway. Genes Dev. 14:45–54.
   PubMedGoogle Scholar
• Huang, S. M., and M. R. Stallcup. 2000. Mouse Zac1, a transcriptional coactivator and repressor for nuclear receptors. Mol. Cell. Biol. 20:1855–1867.
   PubMed Web of Science ®Google Scholar
• Jordan, V. C., and M. Morrow. 1999. Tamoxifen, raloxifene, and the prevention of breast cancer. Endocr. Rev. 20:253–278.
   PubMed Web of Science ®Google Scholar
• Kamei, Y., L. Xu, T. Heinzel, J. Torchia, R. Kurokawa, B. Glass, S.-C. Lin, R. A. Heyman, D. W. Rose, C. K. Glass, and M. G. Rosenfeld. 1996. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403–414.
   PubMed Web of Science ®Google Scholar
• Kao, H. Y., M. Downes, P. Ordentlich, and R. M. Evans. 2000. Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression. Genes Dev. 14:55–66.
   PubMed Web of Science ®Google Scholar
• Kliewer, S. A., J. M. Lehmann, and T. M. Willson. 1999. Orphan nuclear receptors: shifting endocrinology into reverse. Science 284:757–760.
   PubMed Web of Science ®Google Scholar
• Labrie, F., C. Labrie, A. Belanger, J. Simard, S. Gauthier, V. Luu-The, Y. Merand, V. Giguere, B. Candas, S. Luo, C. Martel, S. M. Singh, M. Fournier, A. Coquet, V. Richard, R. Charbonneau, G. Charpenet, A. Tremblay, G. Tremblay, L. Cusan, and R. Veilleux. 1999. EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometrium. J. Steroid Biochem. Mol. Biol. 69:51–84.
   PubMed Web of Science ®Google Scholar
• Le Douarin, B., A. L. Nielsen, J.-M. Garnier, H. Ichinose, F. Jeanmougin, R. Losson, and P. Chambon. 1996. A possible involvement of TIF1α and TIF1β in the epigenic control of transcription by nuclear receptors. EMBO J. 15:6701–6715.
   PubMed Web of Science ®Google Scholar
• Lee, J. W., F. Ryan, J. C. Swaffield, S. A. Johnston, and D. D. Moore. 1995. Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature 374:91–94.
   PubMed Web of Science ®Google Scholar
• Mak, H. Y., S. Hoare, P. M. Henttu, and M. G. Parker. 1999. Molecular determinants of the estrogen receptor-coactivator interface. Mol. Cell. Biol. 19:3895–3903.
   PubMedGoogle Scholar
• Mangelsdorf, D. J., C. Thummel, M. Beato, P. Herrlich, G. Schütz, K. Umesono, B. Blumberg, P. Kastner, M. Mark, P. Chambon, and R. M. Evans. 1995. The nuclear receptor superfamily: the second decade. Cell 83:835–839.
   PubMed Web of Science ®Google Scholar
• McInerney, E. M., and B. S. Katzenellenbogen. 1996. Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation. J. Biol. Chem. 271:24172–24178.
   PubMedGoogle Scholar
• McInerney, E. M., D. W. Rose, S. E. Flynn, S. Westin, T. M. Mullen, A. Krones, J. Inostroza, J. Torchia, R. T. Nolte, N. Assa-Munt, M. V. Milburn, C. K. Glass, and M. G. Rosenfeld. 1998. Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation. Genes Dev. 12:3357–3368.
   PubMed Web of Science ®Google Scholar
• McKenna, N. J., R. B. Lanz, and B. W. O'Malley. 1999. Nuclear receptor coregulators: cellular and molecular biology. Endocr. Rev. 20:321–344.
   PubMed Web of Science ®Google Scholar
• Moras, D., and H. Gronemeyer. 1998. The nuclear receptor ligand-binding domain: structure and function. Curr. Opin. Cell Biol. 10:384–391.
   PubMed Web of Science ®Google Scholar
• Nagy, L., H. Y. Kao, D. Chakravarti, R. J. Lin, C. A. Hassig, D. E. Ayer, S. L. Schreiber, and R. M. Evans. 1997. Nuclear receptor repression mediated by a complex containing SMRT, mSin3a, and histone deacetylase. Cell 89:373–380.
   PubMed Web of Science ®Google Scholar
• Nagy, L., H. Y. Kao, J. D. Love, C. Li, E. Banayo, J. T. Gooch, V. Krishna, K. Chatterjee, R. M. Evans, and J. W. Schwabe. 1999. Mechanism of corepressor binding and release from nuclear hormone receptors. Genes Dev. 13:3209–3216.
   PubMed Web of Science ®Google Scholar
• Norris, J. D., L. A. Paige, D. J. Christensen, C. Y. Chang, M. R. Huacani, D. Fan, P. T. Hamilton, D. M. Fowlkes, and D. P. McDonnell. 1999. Peptide antagonists of the human estrogen receptor. Science 285:744–746.
   PubMed Web of Science ®Google Scholar
• Paech, K., P. Webb, G. G. J. M. Kuiper, S. Nilsson, J.-Å. Gustafsson, P. J. Kushner, and T. S. Scanlan. 1997. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science 277:1508–1510.
   PubMed Web of Science ®Google Scholar
• Perissi, V., L. M. Staszewski, E. M. McInerney, R. Kurokawa, A. Krones, D. W. Rose, M. H. Lambert, M. V. Milburn, C. K. Glass, and M. G. Rosenfeld. 1999. Molecular determinants of nuclear receptor-corepressor interaction. Genes Dev. 13:3198–3208.
   PubMed Web of Science ®Google Scholar
• Rachez, C., B. D. Lemon, Z. Suldan, V. Bromleigh, M. Gamble, A. M. Naar, H. Erdjument-Bromage, P. Tempst, and L. P. Freedman. 1999. Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 398:824–828.
   PubMed Web of Science ®Google Scholar
• Retnakaran, R., G. Flock, and V. Giguère. 1994. Identification of RVR, a novel orphan nuclear receptor that acts as a negative transcriptional regulator. Mol. Endocrinol. 8:1234–1244.
   PubMedGoogle Scholar
• Saatcioglu, F., G. Lopez, B. L. West, E. Zandi, W. Feng, H. Lu, A. Esmaili, J. W. Apriletti, P. J. Kushner, J. D. Baxter, and M. Karin. 1997. Mutations in the conserved C-terminal sequence in thyroid hormone receptor dissociate hormone-dependent activation from interference with AP-1 activity. Mol. Cell. Biol. 17:4687–4695.
   PubMedGoogle Scholar
• Sande, S., and M. L. Privalsky. 1996. Identification of Tracs (T-3 receptor-associating cofactors), a family of cofactors that associate with, and modulate the activity of, nuclear hormone receptors. Mol. Endocrinol. 10:813–825.
   PubMedGoogle Scholar
• Schulman, I. G., H. Juguilon, and R. M. Evans. 1996. Activation and repression by nuclear hormone receptors: hormone modulates an equilibrium between active and repressive states. Mol. Cell. Biol. 16:3807–3813.
   PubMed Web of Science ®Google Scholar
• Shiau, A. K., D. Barstad, P. M. Loria, L. Cheng, P. J. Kushner, D. A. Agard, and G. L. Greene. 1998. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95:927–937.
   PubMed Web of Science ®Google Scholar
• Tanner, M. M., M. Tirkkonen, A. Kallioniemi, C. Collins, T. Stokke, R. Karhu, D. Kowbel, F. Shadravan, M. Hintz, W. L. Kuo, et al.. 1994. Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes. Cancer Res. 54:4257–4260.
   PubMed Web of Science ®Google Scholar
• Tanner, M. M., M. Tirkkonen, A. Kallioniemi, J. Isola, T. Kuukasjarvi, C. Collins, D. Kowbel, X. Y. Guan, J. Trent, J. W. Gray, P. Meltzer, and O. P. Kallioniemi. 1996. Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer. Cancer Res. 56:3441–3445.
   PubMedGoogle Scholar
• Tini, M., G. Otulakowski, M. L. Breitman, L.-T. Tsui, and V. Giguère. 1993. An everted repeat mediates retinoic acid induction of the γF-crystallin gene: evidence of a direct role for retinoids in lens development. Genes Dev. 7:295–307.
   PubMed Web of Science ®Google Scholar
• Tremblay, A., G. B. Tremblay, C. Labrie, F. Labrie, and V. Giguère. 1998. EM-800, a novel antiestrogen, acts as a pure antagonist of the transcriptional functions of estrogen receptors α and β. Endocrinology 139:111–118.
   PubMed Web of Science ®Google Scholar
• Tremblay, G. B., A. Tremblay, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, F. Labrie, and V. Giguère. 1997. Cloning, chromosomal localization and functional analysis of the murine estrogen receptor β. Mol. Endocrinol. 11:353–365.
   PubMed Web of Science ®Google Scholar
• Tremblay, G. B., A. Tremblay, F. Labrie, and V. Giguère. 1998. Ligand-independent activation of the estrogen receptors α and β by mutations of a conserved tyrosine can be abolished by antiestrogens. Cancer Res. 58:877–881.
   PubMedGoogle Scholar
• Treuter, E., L. Johansson, J. S. Thomsen, A. Wärnmark, J. Leers, M. Pelto-Huikko, M. Sjöberg, A. P. Wright, G. Spyrou, and J. Å. Gustafsson. 1999. Competition between thyroid hormone receptor-associated protein (TRAP) 220 and transcriptional intermediary factor (TIF) 2 for binding to nuclear receptors. Implications for the recruitment of TRAP and p160 coactivator complexes. J. Biol. Chem. 274:6667–6677.
   PubMedGoogle Scholar
• Umesono, K., V. Giguère, C. K. Glass, M. G. Rosenfeld, and R. M. Evans. 1988. Retinoic acid and thyroid hormone induce gene expression through a common responsive element. Nature 336:262–265.
   PubMed Web of Science ®Google Scholar
• Wakeling, A. E., and J. Bowler. 1992. ICI 182,780, a new antioestrogen with clinical potential. J. Steroid Biochem. Mol. Biol. 43:173–177.
   PubMed Web of Science ®Google Scholar
• White, R., M. Sjöberg, E. Kalkhoven, and M. G. Parker. 1997. Ligand-independent activation of the estrogen receptor by mutation of a conserved tyrosine. EMBO J. 16:1427–1435.
   PubMed Web of Science ®Google Scholar
• Yang, N. N., M. Venugopalan, S. Hardikar, and A. Glasebrook. 1996. Identification of an estrogen response element activated by metabolites of 17β-estradiol and raloxifene. Science 273:1222–1225.
   PubMed Web of Science ®Google Scholar
• Zamir, I., J. Dawson, R. M. Lavinsky, C. K. Glass, M. G. Rosenfeld, and M. A. Lazar. 1997. Cloning and characterization of a corepressor and potential component of the nuclear hormone receptor repression complex. Proc. Natl. Acad. Sci. USA 94:14400–14405.
   PubMedGoogle Scholar
• Zhang, J., X. Hu, and M. A. Lazar. 1999. A novel role for helix 12 of retinoid X receptor in regulating repression. Mol. Cell. Biol. 19:6448–6457.
   PubMed Web of Science ®Google Scholar